{
    "title": "US congressional report slams FDA approval of Alzheimer's drug",
    "url": "https://www.dailymail.co.uk/wires/afp/article-11583749/US-congressional-report-slams-FDA-approval-Alzheimers-drug.html",
    "date": "2022-12-29",
    "keywords": [
        "drug",
        "approval",
        "biogen",
        "fda",
        "report",
        "process",
        "committee",
        "aduhelm",
        "company",
        "review",
        "year",
        "history",
        "pathway",
        "call",
        "house",
        "integrity",
        "food",
        "investigation",
        "greenlighting",
        "manufacturer",
        "biotechnology",
        "cambridge",
        "price",
        "june",
        "fact",
        "panel",
        "regulator",
        "evidence",
        "benefit",
        "inconsistency",
        "course",
        "period",
        "failure",
        "agency",
        "staff",
        "maker",
        "briefing",
        "document",
        "opportunity",
        "peak",
        "revenue",
        "september",
        "presentation",
        "board",
        "ambition",
        "time",
        "carolyn",
        "maloney",
        "chairwoman",
        "oversight",
        "reform",
        "wakeup",
        "chairman",
        "energy",
        "commerce",
        "greed",
        "decision",
        "search",
        "expediency",
        "precedence",
        "safety",
        "efficacy",
        "core",
        "statement",
        "treatment",
        "decade",
        "innovation",
        "health",
        "challenge"
    ],
    "category": [
        "wires",
        "afp"
    ]
}